| Product NDC: | 10019-179 | 
| Proprietary Name: | Morphine Sulfate | 
| Non Proprietary Name: | Morphine Sulfate | 
| Active Ingredient(s): | 15 mg/mL & nbsp; Morphine Sulfate | 
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 10019-179 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER | 
| Start Marketing Date: | 20100526 | 
| Package NDC: | 10019-179-44 | 
| Package Description: | 25 VIAL in 1 BOX (10019-179-44) > 1 mL in 1 VIAL (10019-179-39) | 
| NDC Code | 10019-179-44 | 
| Proprietary Name | Morphine Sulfate | 
| Package Description | 25 VIAL in 1 BOX (10019-179-44) > 1 mL in 1 VIAL (10019-179-39) | 
| Product NDC | 10019-179 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Morphine Sulfate | 
| Dosage Form Name | INJECTION | 
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 
| Start Marketing Date | 20100526 | 
| Marketing Category Name | UNAPPROVED DRUG OTHER | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | MORPHINE SULFATE | 
| Strength Number | 15 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |